Suppr超能文献

开胸手术和胸膜剥脱术:培养阳性脓胸对手术结果的影响。

Thoracotomy and decortication: impact of culture-positive empyema on the outcome of surgery.

作者信息

Okiror Lawrence, Coltart Cordelia, Bille Andrea, Guile Lucy, Pilling John, Harrison-Phipps Karen, Routledge Tom, Lang-Lazdunski Loic, Hemsley Carolyn, King Juliet

机构信息

Department of Thoracic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK

Department of Clinical Infection Services, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Eur J Cardiothorac Surg. 2014 Nov;46(5):901-6. doi: 10.1093/ejcts/ezu104. Epub 2014 Mar 14.

Abstract

OBJECTIVES

This study aimed to assess the efficacy of thoracotomy and decortication (T/D) in achieving lung re-expansion in patients with Stage III empyema and assess the impact of culture-positive empyema on the outcome of decortication.

METHODS

This is a retrospective observational study of consecutive patients treated with T/D over a 6-year period.

RESULTS

A total of 107 consecutive patients were identified. The median age was 55 (range 16-86) years; of which, 86% were male. The median length of hospital stay was 9 (range 2-45) days. Full lung re-expansion was achieved in 86% of cases. There were no postoperative deaths. Pleural cultures were positive in 56 (52%) cases. Patients with culture-positive empyema had a longer duration of pleural drainage (median of 11 days, range 3-112 versus median of 5 days, range 3-29 days for negative culture; P = 0.0004), longer length of hospital stay (median of 11 days, range 4-45 versus median of 7 days, range 2-34 days; P = 0.0002) and more complications (P = 0.0008), respectively. There was no statistically significant difference in the outcome of surgery, i.e. lung re-expansion versus trapped lung (P = 0.08) between the two groups.

CONCLUSIONS

T/D is safe and achieved lung re-expansion in the majority of patients. Culture-positive empyema was associated with worse outcomes.

摘要

目的

本研究旨在评估开胸手术及胸膜剥脱术(T/D)对Ⅲ期脓胸患者实现肺复张的疗效,并评估培养阳性脓胸对胸膜剥脱术结局的影响。

方法

这是一项对连续6年接受T/D治疗患者的回顾性观察研究。

结果

共确定了107例连续患者。中位年龄为55岁(范围16 - 86岁);其中86%为男性。中位住院时间为9天(范围2 - 45天)。86%的病例实现了肺完全复张。无术后死亡病例。56例(52%)胸膜培养呈阳性。培养阳性脓胸患者的胸膜引流持续时间更长(中位11天,范围3 - 112天,而培养阴性患者中位5天,范围3 - 29天;P = 0.0004),住院时间更长(中位11天,范围4 - 45天,而中位7天,范围2 - 34天;P = 0.0002),并发症更多(P = 0.0008)。两组手术结局,即肺复张与肺陷闭之间无统计学显著差异(P = 0.08)。

结论

T/D是安全的,且在大多数患者中实现了肺复张。培养阳性脓胸与更差的结局相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验